Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets
To exploit highly conserved and difficult drug targets, including multipass membrane proteins, monoclonal antibody discovery efforts increasingly rely on the advantages offered by divergent species such as rabbits, camelids, and chickens. Here, we provide an overview of antibody discovery technologi...
Saved in:
Main Authors: | Soma S.R. Banik, Natasha Kushnir, Benjamin J. Doranz, Ross Chambers |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2023.2273018 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
VERITAS: Harnessing the power of nomenclature in biologic discovery
by: Riti Biswas, et al.
Published: (2023-12-01) -
Developing drug-like single-domain antibodies (VHH) from in vitro libraries
by: M. Frank Erasmus, et al.
Published: (2025-12-01) -
A pan-beta-coronavirus vaccine bearing conserved and asymptomatic B- and T-cell epitopes protects against highly pathogenic Delta and highly transmissible Omicron SARS-CoV-2 variants
by: Hawa Vahed, et al.
Published: (2025-12-01) -
Evolution of phage display libraries for therapeutic antibody discovery
by: Yang Zhang
Published: (2023-12-01) -
Identification and epitope mapping of anti-p72 single-chain antibody against African swine fever virus based on phage display antibody library
by: Jin-xing SONG, et al.
Published: (2023-09-01)